Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T MacDonald

Showing results (151-160 of 524) with videos related to

Pageof 53
Sort By:
Journal of Clinical Pathology|November 1, 1977
Technique for microdissection and measurement in biopsies of human small intestineA Ferguson, A Sutherland, T T MacDonald, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 26, 2013
Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary resultsSimon T MacDonald, Matthew J Daniels, Oliver J Ormerod
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Reprogramming the immune system in IBDThomas T MacDonald, Anna Vossenkaemper, Massimo Fantini, et al.
Immunology|April 1, 1989
T-cell receptor expression in intestinal intra-epithelial lymphocyte subpopulations of normal and athymic miceJ L Viney, T T MacDonald, P J Kilshaw
Environmental Monitoring and Assessment|March 30, 2017
Earth-tide-induced fluctuations in the salinity of an inland river, New South Wales, Australia: a short-term studyJ F Jasonsmith, B C T Macdonald, I White
Current Opinion in Gastroenterology|June 3, 2005
The pathophysiologic rationale for biological therapies in inflammatory bowel diseaseJohn N Gordon, Antonio Di Sabatino, Thomas T Macdonald
The American Journal of Physiology|September 14, 1999
Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidneyM D Okusa, J Linden, T Macdonald, et al.
Infection and Immunity|February 1, 1988
Multigenic control of resistance to Yersinia enterocolitica in inbred strains of miceG E Hancock, R W Schaedler, T T MacDonald
Oncoimmunology|June 28, 2012
Interleukin-21 in cancer immunotherapy: Friend or foe?Carmine Stolfi, Francesco Pallone, Thomas T Macdonald, et al.
British Journal of Clinical Pharmacology|December 4, 2003
The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertensionD Patterson, J Webster, G McInnes, et al.
Pageof 53

Showing results (151-160 of 524) with videos related to

Sort By:
Pageof 53
Journal of Clinical Pathology|November 1, 1977
Technique for microdissection and measurement in biopsies of human small intestineA Ferguson, A Sutherland, T T MacDonald, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 26, 2013
Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary resultsSimon T MacDonald, Matthew J Daniels, Oliver J Ormerod
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Reprogramming the immune system in IBDThomas T MacDonald, Anna Vossenkaemper, Massimo Fantini, et al.
Immunology|April 1, 1989
T-cell receptor expression in intestinal intra-epithelial lymphocyte subpopulations of normal and athymic miceJ L Viney, T T MacDonald, P J Kilshaw
Environmental Monitoring and Assessment|March 30, 2017
Earth-tide-induced fluctuations in the salinity of an inland river, New South Wales, Australia: a short-term studyJ F Jasonsmith, B C T Macdonald, I White
Current Opinion in Gastroenterology|June 3, 2005
The pathophysiologic rationale for biological therapies in inflammatory bowel diseaseJohn N Gordon, Antonio Di Sabatino, Thomas T Macdonald
The American Journal of Physiology|September 14, 1999
Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidneyM D Okusa, J Linden, T Macdonald, et al.
Infection and Immunity|February 1, 1988
Multigenic control of resistance to Yersinia enterocolitica in inbred strains of miceG E Hancock, R W Schaedler, T T MacDonald
Oncoimmunology|June 28, 2012
Interleukin-21 in cancer immunotherapy: Friend or foe?Carmine Stolfi, Francesco Pallone, Thomas T Macdonald, et al.
British Journal of Clinical Pharmacology|December 4, 2003
The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertensionD Patterson, J Webster, G McInnes, et al.
Pageof 53